Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

被引：0
|
作者：
Kerstin Michalski
Juri Ruf
Christian Goetz
Anna Katharina Seitz
Andreas K. Buck
Constantin Lapa
Philipp E. Hartrampf
机构：
[1] Medical Center-University of Freiburg,Department of Nuclear Medicine, Faculty of Medicine
[2] University Hospital Würzburg,Department of Urology and Paediatric Urology
[3] University Hospital Würzburg,Department of Nuclear Medicine
[4] University of Augsburg,Nuclear Medicine, Medical Faculty
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词：
PSMA; FDG; PET/CT; Prostate cancer; Radioligand therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2024 / 2030
页数：6
相关论文
共 50 条
  • [1] Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
    Michalski, Kerstin
    Ruf, Juri
    Goetz, Christian
    Seitz, Anna Katharina
    Buck, Andreas K.
    Lapa, Constantin
    Hartrampf, Philipp E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (06) : 2024 - 2030
  • [2] Prognostic implications of dual tracer PET/CT: additional FDg PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
    Michalski, K.
    Ruf, J.
    Meyer, P.
    Buck, A.
    Lapa, C.
    Hartrampf, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S694 - S694
  • [3] EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
    Fanti, Stefano
    Kunikowska, Jolanta
    Walz, Jochen
    Witjes, Wim
    Bjartell, Anders
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (10) : 3328 - 3329
  • [4] EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
    Stefano Fanti
    Jolanta Kunikowska
    Jochen Walz
    Wim Witjes
    Anders Bjartell
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3328 - 3329
  • [5] Combined [18F]FDG and [68Ga]Ga-PSMA-11 PET/CT for [177Lu]-PSMA-Radioligand therapy assessment with long-axial field of view (LAFOV) PET/CT
    Alberts, I.
    Schepers, R.
    Zeimpekis, K.
    Viscione, M.
    Rominger, A.
    Afshar-Oromieh, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S268 - S268
  • [6] The prognostic value of whole-body composition analysis in prostate cancer patients undergoing [177Lu] PSMA radioligand therapy: A Proof of concept study using pretherapeutic [18F]PSMA PET-CT
    Roll, W.
    Plagwitz, L.
    Varghese, J.
    Ventura, D.
    Rahbar, K.
    Schindler, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S361 - S361
  • [7] Dual PSMA/FDG PET/CT for assessing eligibility and predicting response in mCRPC patients undergoing 177Lu-PSMA-617 radioligand therapy: A post-VISION analysis
    Babu, Anushna S.
    Tripathi, Madhavi
    Yadav, Madhav
    Ballal, Sanjana
    Satapathy, Swayamjeet
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [8] Imaging screening with [68Ga]-Ga-PSMA-11, [18F]F-FDG, and [18F]-FCholine PET/CT for [177Lu]-PSMA radioligand therapy eligibility in metastatic castration-resistant prostate cancer
    Djaileb, L.
    de Leiris, N.
    Chanchou, M.
    Paquet, E.
    Margail, C.
    Faure, M.
    Drouet, C.
    Le Bon, S.
    Ruggeri, V.
    Farolfi, A.
    Gafita, A.
    Castellucci, P.
    Barbato, F.
    Oprea-Lager, D.
    Cysouw, M.
    Burger, I.
    Ceci, F.
    Mairal, E.
    Blanc-Durand, P.
    Calais, J.
    Fendler, W.
    Herrmann, K.
    Cachin, F.
    Giraudet, A.
    Merlin, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S550 - S550
  • [9] PSMA PET/CT for Response Assessment of 177Lu-PSMA Therapy
    Hartrampf, Philipp E.
    Serfling, Sebastian E.
    Michalski, Kerstin
    Buck, Andreas K.
    Werner, Rudolf A.
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 69 - 76
  • [10] Added Value of Interim FDG PET/CT Imaging for Patients with Metastatic Prostate Cancer Undergoing 177Lu-PSMA Radioligand Therapy
    Leger, M.
    Tahmi, D.
    Zeiter, R. Latif
    Shagera, Q.
    Guiot, T.
    Manley, M.
    Flamen, P.
    Artigas, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S329 - S329
12345